Cycle Pharmaceuticals was founded in 2012 with the sole aim of delivering best-in-class drug treatments and services to the under-served rare disease patient community.
View all
Curia
Albany, United States
Sleepio
Seed • London, United Kingdom
4D Pharma
Post IPO Equity • Aberdeen, United Kingdom
Sygnature Discovery Limited
Secondary Market • Nottingham, United Kingdom
Yourgene Health
Manchester, United Kingdom
Hikma Pharmaceuticals
England, United Kingdom
Redx Pharma
Grant • England, United Kingdom
GSK
Brentford, United Kingdom
Mundipharma
Cambridge, United Kingdom
BIOShealth
Seed • Cambridge, United Kingdom
AstraZeneca
Cambridge, United Kingdom
GW Pharmaceuticals
Post IPO Equity • Porton Down, United Kingdom